- 2025-05-20 09:54Cenacitinib 2641636-52-2
- 2025-05-20 09:54LSD1/2-IN-4 2821068-09-9
- 2025-05-20 09:54TP-238 hydrochloride 2415263-05-5
- 2025-05-20 09:54E67-2 1364914-62-4
- 2025-05-20 09:54LSD1/2-IN-3 2821068-07-7
- 2025-05-20 09:54TP-238 2415263-04-4
- 2025-05-20 09:54DS-437 1674364-87-4
- 2025-05-20 09:54BVB808 1414587-22-6
- 2025-05-20 09:54LSD1-UM-109 2252446-26-5
- 2025-05-20 09:54TMX1
- 2025-05-20 09:54Butyzamide 1110767-45-7
- 2025-05-20 09:53LSD1-IN-38
- 2025-05-20 09:53Dot1L-IN-9
- 2025-05-20 09:53Thalidomide-NH-CBP/p300 ligand 2 2484739-21-9
- 2025-05-20 09:53BPC 157 acetate 1628202-19-6
- 2025-05-20 09:53LSD1-IN-37
- 2025-05-20 09:53Dot1L-IN-8
- 2025-05-20 09:53TCIP 1
- 2025-05-20 09:53BMS-911543 1271022-90-2
- 2025-05-20 09:53LSD1-IN-35 2992690-04-5
